Genetically modified herpes combats advanced cancers
A new genetically engineered virus has delivered a one-two punch in initial phase 1 trial
Read More
Tag: herpes
Gilead licenses respiratory, herpes antiviral research programs from Novartis
The antivirus programs include investigational agents with the potential to treat human rhinovirus, influenza and herpes viruses.
Read More
- Strong clinical data for Breye lead asset danegaptide
- EHP Awards triumph
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
